We confirmed that this was not due to antigen loss by evaluating PSCA and MUC1 surface levels on outgrowing tumor cells (on day 20), which demonstrated expression of both antigens comparable to the untreated condition (Figure 1G). The gene discussed is MUC1; the disease is neoplasm.